PMID: 33692036DOI: 10.1136/archdischild-2021-321775Mar 12, 2021Paper

Olanzapine was an effective additional antiemetic for children and young people undergoing highly emetogenic chemotherapy.

Archives of Disease in Childhood. Education and Practice Edition

Amanda Jane Friend, Bob Phillips

Abstract

No abstract listed.

References

The safety of olanzapine in young children: a systematic review and meta-analysis

Aug 26, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jacqueline FlankL Lee Dupuis

Safety of clinical practice guideline-recommended antiemetic agents for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients: a systematic review and meta-analysis

Jan 15, 2019·Expert Opinion on Drug Safety·Priya PatelL Lee Dupuis

Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials.

Feb 23, 2020·ESMO Open·Jian-Guo ZhouUdo S Gaipl

❮ Previous

Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children

(opens in new tab)

Children

So Rae LeeJae Min Lee

Olanzapine is an effective antiemetic agent.

(opens in new tab)

Annals of Palliative Medicine

Rudolph M Navari, Charles L Loprinzi

Survey ranking of emetogenic control in children receiving chemotherapy

(opens in new tab)

Journal of Pediatric Hematology/oncology

B E SmallS S Winter

Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy

(opens in new tab)

Japanese Journal of Clinical Oncology

Hironobu HashimotoYuichiro Ohe

A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center

(opens in new tab)

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners

Mohammed AseeriWasil Jastaniah

Contact Help Terms Privacy Cookies

© 2022 Meta ULC. All rights reserved